scholarly article | Q13442814 |
P356 | DOI | 10.1007/S13277-014-2170-Z |
P698 | PubMed publication ID | 24903383 |
P2093 | author name string | Wu-Hsien Kuo | |
Shun-Fa Yang | |||
Ming-Ju Hsieh | |||
Hsiang-Lin Lee | |||
Hsiu-Ting Tsai | |||
Hui-Ling Chiou | |||
Yi-Sheng Liou | |||
Chen-Chieh Yang | |||
Min-Chieh Hsin | |||
P2860 | cites work | Treatment of hepatocellular carcinoma | Q73043043 |
Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26 | Q28273704 | ||
CpG island methylation and expression of tumour-associated genes in lung carcinoma | Q30320221 | ||
Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. | Q33514753 | ||
Glutathione S-Transferase P1 (GSTP1) gene polymorphism increases age-related susceptibility to hepatocellular carcinoma | Q33544926 | ||
TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. | Q33754007 | ||
Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms | Q34074796 | ||
Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma. | Q34341560 | ||
Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression | Q34573212 | ||
Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma | Q35699313 | ||
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice. | Q35927161 | ||
Management of hepatocellular carcinoma in Japan | Q36433760 | ||
Immunotherapy: rAAV2 expressing interleukin-15 inhibits HeLa cell tumor growth in mice | Q37204756 | ||
Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival | Q37351433 | ||
Challenge and hope in radiotherapy of hepatocellular carcinoma | Q37400936 | ||
Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma | Q38585070 | ||
Estrogen receptor 1 gene as a tumor suppressor gene in hepatocellular carcinoma detected by triple-combination array analysis | Q39149008 | ||
Curcumin effect on MMPs and TIMPs genes in a breast cancer cell line. | Q39275147 | ||
MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells | Q39913331 | ||
Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3. | Q40644810 | ||
Alcohol modulation of cardiac matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs favors collagen accumulation | Q41774444 | ||
Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma. | Q42925381 | ||
Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues | Q43200969 | ||
Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells | Q43481636 | ||
Immunotherapy of breast cancer by single delivery with rAAV2-mediated interleukin-15 expression | Q44017139 | ||
Promoter hypomethylation of TIMP3 is associated with pre-eclampsia in a Chinese population | Q44037768 | ||
Promoter polymorphism (rs3755724, -55C/T) of tissue inhibitor of metalloproteinase 4 (TIMP4) as a risk factor for Kawasaki disease with coronary artery lesions in a Korean population | Q44581830 | ||
Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice | Q46232844 | ||
Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. | Q48048643 | ||
Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility. | Q50863404 | ||
CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinoma. | Q54321502 | ||
Predicting invasive phenotype with CDH1, CDH13, CD44, and TIMP3 gene expression in primary breast cancer. | Q54462431 | ||
Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors. | Q54785034 | ||
Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas. | Q55471677 | ||
Endometrial expression of the estrogen-sensitive genes MMP-26 and TIMP-4 is altered by a substitution protocol without down-regulation in IVF patients | Q57607660 | ||
Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk | Q58814554 | ||
P433 | issue | 9 | |
P304 | page(s) | 8999-9007 | |
P577 | publication date | 2014-06-07 | |
P1433 | published in | Tumor Biology | Q15757842 |
P1476 | title | TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women | |
P478 | volume | 35 |
Q61444155 | Association of TIMP4 gene variants with steroid-induced osteonecrosis of the femoral head in the population of northern China |
Q42146970 | Genetic polymorphisms in antioxidant enzyme genes and susceptibility to hepatocellular carcinoma in Chinese population: a case-control study |
Q36299328 | Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer |
Q64057740 | Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study |
Q92277219 | TIMP-3 as a therapeutic target for cancer |
Search more.